Eladio Crego Gil is the founder and CEO of EFT Innovation, specializing in scaling tech companies within the biotechnology and photonics sectors. Educated at Esade and the Universidad de Santiago de Compostela, he leverages over a decade of experience to bridge the gap between science and business, also serving on multiple startup boards.
His interests lie at the intersection of business strategy and scientific advancement, particularly within the pharmaceutical industry. He actively follows major companies like Pfizer, GSK, and Sanofi, and business publications such as the Harvard Business Review, reflecting a commitment to continuous learning in both domains.
He co-founded iPRONICS, a pioneering company that develops programmable photonic circuits, showcasing his direct experience in launching deep-tech ventures.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.